Literature DB >> 20670885

Dangerous liaisons: Fanconi anemia and toxic nonhomologous end joining in DNA crosslink repair.

Samuel F Bunting1, André Nussenzweig.   

Abstract

The proper choice of repair pathway is critical to tolerating various types of DNA damage. In a recent issue of Molecular Cell, Adamo et al. (2010), along with a second report (Pace et al., 2010), describe how the Fanconi anemia (FA) pathway is involved in preventing aberrant DNA repair. These studies suggest a potentially significant new opportunity for the treatment of FA. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID: 20670885      PMCID: PMC6591721          DOI: 10.1016/j.molcel.2010.07.016

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  17 in total

Review 1.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

Authors:  Hyungjin Kim; Alan D D'Andrea
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

Review 2.  Fanconi anemia: a disorder defective in the DNA damage response.

Authors:  Hiroyuki Kitao; Minoru Takata
Journal:  Int J Hematol       Date:  2011-02-18       Impact factor: 2.490

3.  Chronic myelogenous leukemia stem and progenitor cells demonstrate chromosomal instability related to repeated breakage-fusion-bridge cycles mediated by increased nonhomologous end joining.

Authors:  Sujata Chakraborty; Jeremy M Stark; Can-Lan Sun; Hardik Modi; WenYong Chen; Timothy R O'Connor; Stephen J Forman; Smita Bhatia; Ravi Bhatia
Journal:  Blood       Date:  2012-04-04       Impact factor: 22.113

4.  Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection.

Authors:  Mu-Yan Cai; Connor E Dunn; Wenxu Chen; Bose S Kochupurakkal; Huy Nguyen; Lisa A Moreau; Geoffrey I Shapiro; Kalindi Parmar; David Kozono; Alan D D'Andrea
Journal:  Cell Rep       Date:  2020-02-18       Impact factor: 9.423

Review 5.  What is wrong with Fanconi anemia cells?

Authors:  Sharon B Cantor; Robert M Brosh
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 6.  Biochemical and cell biological assays to identify and characterize DNA helicase inhibitors.

Authors:  Taraswi Banerjee; Monika Aggarwal; Joshua A Sommers; Robert M Brosh
Journal:  Methods       Date:  2016-04-07       Impact factor: 3.608

7.  Werner syndrome helicase has a critical role in DNA damage responses in the absence of a functional fanconi anemia pathway.

Authors:  Monika Aggarwal; Taraswi Banerjee; Joshua A Sommers; Chiara Iannascoli; Pietro Pichierri; Robert H Shoemaker; Robert M Brosh
Journal:  Cancer Res       Date:  2013-07-18       Impact factor: 12.701

8.  Targeting an Achilles' heel of cancer with a WRN helicase inhibitor.

Authors:  Monika Aggarwal; Taraswi Banerjee; Joshua A Sommers; Robert M Brosh
Journal:  Cell Cycle       Date:  2013-09-12       Impact factor: 4.534

9.  Regulation of Rev1 by the Fanconi anemia core complex.

Authors:  Hyungjin Kim; Kailin Yang; Donniphat Dejsuphong; Alan D D'Andrea
Journal:  Nat Struct Mol Biol       Date:  2012-01-22       Impact factor: 15.369

10.  DNA interstrand cross-link repair requires replication-fork convergence.

Authors:  Jieqiong Zhang; James M Dewar; Magda Budzowska; Anna Motnenko; Martin A Cohn; Johannes C Walter
Journal:  Nat Struct Mol Biol       Date:  2015-02-02       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.